Skip to content
Open access

Integrative multi-omics and machine learning analysis identifies candidate biomarkers associated with mitochondrial quality control in major depressive disorder

Aug 2026 · Frontiers in Psychiatry · Vol 17 · 0 citations · 82 references
Medicine

TL;DR

DCHS1 and HS3ST2 may serve as candidate biomarkers associated with MQC-related transcriptional alterations in the PFC of patients with MDD, providing preliminary, hypothesis-generating evidence for the link between MQC-related transcriptional dysregulation and MDD.

Abstract

Background Major depressive disorder (MDD) possesses a complex pathogenesis, with abnormal mitochondrial quality control (MQC) proposed as a potential mechanism involved in the pathological process. Methods This study integrated two microarray expression profiling datasets with a single-nucleus RNA sequencing (snRNA-seq) dataset from the human prefrontal cortex (PFC). Candidate genes were identified by intersecting differentially expressed genes (DEGs) from the training set with MQC-associated module genes identified through WGCNA. Ten machine learning algorithms ranked MQC-associated candidate biomarkers, followed by preliminary mRNA-level verification using PFC tissues from chronic restraint stress (CRS) rats. Additionally, MQC-related gene set activity was computationally inferred at the single-cell level to examine cell-type-specific transcriptional alterations associated with MDD. Results The application of ten machine learning algorithms highlighted DCHS1 and HS3ST2 as candidate biomarkers linked to MQC-related transcriptional alterations. Gene set enrichment analysis (GSEA) indicated associations of these genes with oxidative phosphorylation and cytokine-cytokine receptor interaction pathways. In CRS rats, DCHS1 mRNA expression decreased, while HS3ST2 mRNA expression increased, aligning with bioinformatic findings. Among the 18 annotated cell types in the snRNA-seq dataset, computationally inferred MQRG activity significantly decreased in eight cell types, including several excitatory and inhibitory neuronal subtypes. Inhib_GRIK1 neurons exhibited cell-type-specific expression differences in DCHS1 and HS3ST2. Conclusion DCHS1 and HS3ST2 may serve as candidate biomarkers associated with MQC-related transcriptional alterations in the PFC of patients with MDD. MQRG activity demonstrated marked cell-type heterogeneity and reduction across multiple PFC cell populations. These findings provide preliminary, hypothesis-generating evidence for the link between MQC-related transcriptional dysregulation and MDD; however, further functional experiments are necessary to ascertain whether DCHS1 and HS3ST2 directly regulate mitochondrial quality control.

Read PDF

Similar papers

Open access Aug 2026

Screening of Key Biomarkers and Molecular Mechanisms of Major Depressive Disorder Based on Multi-Cohort Transcriptomic Data

The onset and progression of MDD may be closely associated with myelin structural damage, membrane lipid metabolic disturbance, neuroinflammation, oxidative stress, and energy metabolic dysregulation, leading to key molecular markers with diagnostic potential being identified.

Jie Fang · 0 citations
Open access Aug 2026

Integrative transcriptomic and machine learning analyses identify NOL7 and TXLNA as candidate blood biomarkers for Parkinson’s disease within an RNA modification-associated co-expression network

Parkinson’s disease (PD) pathogenesis involves complex molecular mechanisms, with emerging evidence implicating RNA modifications (RM). This study sought to explore RM-associated key genes and their roles in PD progression. Transcriptomic datasets GSE6613 (training) and GSE72267 (validation) were analyze...

Mei-Ling Chen, Peng Chen, Liya Suo et al. · 0 citations
Open access Sep 2026

Machine Learning-Guided Multi-Omics Integration Identifies UGCG as a Candidate Lipid Metabolic Biomarker and Potential Therapeutic Target in Sepsis

Background Sepsis is a highly lethal organ dysfunction syndrome characterized by dysregulation of the host immune response. This study aims to identify robust lipid metabolism-related genes (LMRGs) as candidate diagnostic biomarkers and to elucidate their underlying immunometabolic mechanisms. Methods We integrated two...

Feng-Chen Lv, Xin Wang, Li Hu · 0 citations
Open access Sep 2026

Cell Tropism-Related Gene Signatures in MDD Identified by Transcriptomic Analysis and Rat Model Validation

Major depressive disorder (MDD) is associated with immune dysregulation, but the contribution of chemotaxis-related genes remains incompletely understood. This study aimed to identify chemotaxis-related signatures in MDD and evaluate their diagnostic relevance. Two peripheral-blood microarray datasets (GSE76826 and GSE...

Jie Min, Rong-Rong Jiang, Qiu-Yue Xu et al. · 0 citations
Open access Sep 2026

Integrative Transcriptomic and Network Pharmacology Analysis Reveals Candidate Molecular Associations and Hypothesis-Generating Drug-Gene Relationships in Major Depressive Disorder

The data support exploratory molecular associations involving stress-response and immune/chemokine-related genes but do not establish causal mechanisms, validated biomarkers, or therapeutic efficacy and require covariate-adjusted replication and experimental validation.

Laura Gomes Libório, Sophia Massesine Pimentel, Sara Laíse Cordeiro · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.